Modernа going to make a profit from the sale of his vaccines
Discuss the cost of the vaccine from Moderna was significantly higher than that offered by other developers.
American biotechnology company Moderna in talks to sell its vaccine coronavirus at a price of $25-30 per dose. The course of her vaccinations will cost $50-60, reports Financial Time, citing sources familiar with the negotiations with potential buyers.
This price provides for the United States and other countries with high income levels, but, as the newspaper notes, it is unlikely to be the final, as the cost, discuss with Moderna, was significantly higher than that offered by other developers of vaccines against COVID-19.
Thus, the American Pfizer and its German partner BioNTtech going to sell US 100 million doses of vaccine at $19,5. A British-Swedish AstraZeneca has signed a deal to sell doses of the future vaccine for $3-4 France, Italy, Germany and the Netherlands.
Moderna, Pfizer, and Merck previously said they were going to profit from the sale of their vaccines, while AstraZeneca and Johnson & Johnson are not going to reap the profits, at least in the early stages of the pandemic.
Earlier it was reported that this week Moderna began testing his vaccine on 30 thousand volunteers – is the largest test in the world.